Literature DB >> 9088267

Familial prostate cancer: the evidence and the Cancer Research Campaign/British Prostate Group (CRC/BPG) UK Familial Prostate Cancer Study.

R A Eeles1, D P Dearnaley, A Ardern-Jones, R J Shearer, D F Easton, D Ford, S Edwards, A Dowe.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9088267     DOI： 10.1111/j.1464-410x.1997.tb00795.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN： 0007-1331


× No keyword cloud information.
  11 in total

Review 1.  Risk factors for prostate cancer.

Authors:  Amit R Patel; Eric A Klein
Journal:  Nat Clin Pract Urol       Date:  2009-02

2.  Better screened than sorry!-an informed panel of inherited DNA repair gene variants for prostate cancer screening and prognostication.

Authors:  Giulia Fracassi; Francesca Lorenzin; Francesca Demichelis
Journal:  Ann Transl Med       Date:  2019-07

3.  Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators.

Authors:  R A Eeles; F Durocher; S Edwards; D Teare; M Badzioch; R Hamoudi; S Gill; P Biggs; D Dearnaley; A Ardern-Jones; A Dowe; R Shearer; D L McLellan; D L McLennan; R L Norman; P Ghadirian; A Aprikian; D Ford; C Amos; T M King; F Labrie; J Simard; S A Narod; D Easton; W D Foulkes
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

4.  Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.

Authors:  S M Edwards; D G R Evans; Q Hope; A R Norman; Y Barbachano; S Bullock; Z Kote-Jarai; J Meitz; A Falconer; P Osin; C Fisher; M Guy; S G Jhavar; A L Hall; L T O'Brien; B N Gehr-Swain; R A Wilkinson; M S Forrest; D P Dearnaley; A T Ardern-Jones; E C Page; D F Easton; R A Eeles
Journal:  Br J Cancer       Date:  2010-08-24       Impact factor: 7.640

5.  Germline BRCA1 mutations increase prostate cancer risk.

Authors:  D Leongamornlert; N Mahmud; M Tymrakiewicz; E Saunders; T Dadaev; E Castro; C Goh; K Govindasami; M Guy; L O'Brien; E Sawyer; A Hall; R Wilkinson; D Easton; D Goldgar; R Eeles; Z Kote-Jarai
Journal:  Br J Cancer       Date:  2012-05-08       Impact factor: 7.640

6.  BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.

Authors:  Z Kote-Jarai; D Leongamornlert; E Saunders; M Tymrakiewicz; E Castro; N Mahmud; M Guy; S Edwards; L O'Brien; E Sawyer; A Hall; R Wilkinson; T Dadaev; C Goh; D Easton; D Goldgar; R Eeles
Journal:  Br J Cancer       Date:  2011-09-27       Impact factor: 7.640

7.  The clinical genetics of prostate cancer.

Authors:  Sashi Kommu; Stephen Edwards; Rosalind Eeles
Journal:  Hered Cancer Clin Pract       Date:  2004-07-15       Impact factor: 2.857

8.  Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer.

Authors:  Alsmawal A Elimam; Mohamed Elmogtba Mouaweia Mohamed Aabdein; Mohamed El-Fatih Moly Eldeen; Hisham N Altayb; Mohamed Adel Taha; Mohammed N Nimir; Mohamed D Dafaalla; Musaab M Alfaki; Mohamed A Abdelrahim; Abdelmohaymin A Abdalla; Musab I Mohammed; Mona Ellaithi; Muzamil Mahdi Abdel Hamid; Mohamed Ahmed Salih Hassan
Journal:  BMC Med Genet       Date:  2017-08-16       Impact factor: 2.103

9.  Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.

Authors:  Martina Mijuskovic; Edward J Saunders; Daniel A Leongamornlert; Sarah Wakerell; Ian Whitmore; Tokhir Dadaev; Clara Cieza-Borrella; Koveela Govindasami; Mark N Brook; Christopher A Haiman; David V Conti; Rosalind A Eeles; Zsofia Kote-Jarai
Journal:  Br J Cancer       Date:  2018-06-19       Impact factor: 7.640

10.  Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease.

Authors:  D Leongamornlert; E Saunders; T Dadaev; M Tymrakiewicz; C Goh; S Jugurnauth-Little; I Kozarewa; K Fenwick; I Assiotis; D Barrowdale; K Govindasami; M Guy; E Sawyer; R Wilkinson; A C Antoniou; R Eeles; Z Kote-Jarai
Journal:  Br J Cancer       Date:  2014-02-20       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.